Recent Submissions

• The impact of increased pharmacy schools on pharmacists’ income: is it still an attractive profession?
• Development of permeation enhancer-Co-loaded solid lipid nanoparticles for enhanced oral bioavailability of alendronate
• Distinct roles of Lactobacillus species in trophoblast invasion: Lactobacillus iners fails to promote HTR-8/SVneo cell invasion unlike Lactobacillus crispatus
• Advances in JNK inhibitor development: therapeutic prospects in neurodegenerative diseases and fibrosis
• Lipid nanoparticle-assisted mRNA therapy for cancer treatment
• A versatile toolkit for drug metabolism studies with GNPS2: from drug development to clinical monitoring
• Molecular perspectives on protein-modulated tear film lipid layer stability in dry eye disease
• Iron overload and oxidative stress participated in zinc oxide nanoparticles-induced blood-brain barrier dysfunction
• Glucocorticoid-Mediated Skeletal Muscle Atrophy: Molecular Mechanisms and Potential Therapeutic Targets
• Phytochemical inhibition of quorum sensing and biofilm formation by Paederia foetida Linn. against multidrug-resistant Acinetobacter baumannii: An integrated in vitro and in silico investigation
• The Regulatory Role of Specific Noncoding RNAs in Brain Pathophysiology
• Polyhexamethylene guanidine-phosphate enhances pro-coagulant activity of human erythrocytes and venous thrombosis in rats through phosphatidylserine externalization
• Public perceptions of high-cost cancer drugs and the implications for reimbursement decisions
• Enrollment Motivations, Career Perceptions, and Preferences of Pharmacy Students under a Changing Educational Landscape: An Exploratory Survey at a Single Institution in South Korea
• uPAR-targeted senolytic delivery to enhance cancer therapy
• Public perceptions of pharmacy services: Perceived importance and face-to-face preference across service stages in the era of digital health
• TSG6 promotes epithelial-mesenchymal transition and tumor-associated macrophage polarization through Smad2/3 and MAPK signaling by facilitating TSG6-CD44-TGFβR1 or EGFR complex formation
• Targeting CD73 with Small Molecule Inhibitors for Enhanced Cancer Immunotherapy
• CSF-1R Inhibition as a Therapeutic Avenue for Neuroinflammation and Neurodegeneration
• Isoform-selective PLK1 inhibitors as targeted therapeutics: design, synthesis, and evaluation in non-small cell lung cancer